Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: Results from the national institutes of health multi-site study

Liver Transplantation

Volumn 19, Issue 6, 2013, Pages 619-626

  Bahirwani, Ranjeeta ^a   Barin, Burc ^b   Olthoff, Kim ^a   Stock, Peter ^c   Murphy, Barbara ^d   Rajender Reddy, K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b EMMES CORPORATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; AGE; BLOOD; CLINICAL TRIAL; COMPLICATION; HIV INFECTIONS; INCIDENCE; LIVER FAILURE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NATIONAL HEALTH ORGANIZATION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; UNITED STATES; VIROLOGY;

ADULT; AGE FACTORS; COINFECTION; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATIONAL INSTITUTES OF HEALTH (U.S.); PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; UNITED STATES;

EID: 84878342686     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23648     Document Type: Article

References (19)

1. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (suppl 1): S1-S266.
2. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
3. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, Sarnak MJ,. The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis 2008; 51: 212-223.
4. McGuire BM, Julian BA, Bynon JS Jr, Cook WJ, King SJ, Curtis JJ, et al. Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 2006; 144: 735-741.
5. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA,. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl 2004; 10: 349-355.
6. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL,. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-599.
7. Macías J, Melguizo I, Fernández-Rivera FJ, García-García A, Mira JA, Ramos AJ, et al. Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy. Eur J Clin Microbiol Infect Dis 2002; 21: 775-781.
8. Pineda JA, Romero-Gõmez M, Díaz-García F, Girõn-González JA, Montero JL, Torre-Cisneros J, et al.; for Grupo Andaluz para el Estudio de las Enfermedades Infecciosas and Grupo Andaluz para el Estudio del Hígado. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 2005; 41: 779-789.
9. Rachakonda AK, Kimmel PL,. CKD in HIV-infected patients other than HIV-associated nephropathy. Adv Chronic Kidney Dis 2010; 17: 83-93.
10. Jao J, Wyatt CM,. Antiretroviral medications: adverse effects on the kidney. Adv Chronic Kidney Dis 2010; 17: 72-82.
11. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB,. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004; 10: 301-309.
12. Fishman JA,. Transplantation for patients infected with human immunodeficiency virus: no longer experimental but not yet routine. J Infect Dis 2003; 188: 1405-1411.
13. Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006; 166: 1632-1641.
14. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008; 8: 355-365.
15. Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD,. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant 2008; 8: 2243-2251.
16. Lafayette RA, Paré G, Schmid CH, King AJ, Rohrer RJ, Nasraway SA,. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol 1997; 48: 159-164.
17. Bahirwani R, Shaked O, Kurd S, Bloom R, Reddy KR,. Chronic kidney disease after orthotopic liver transplantation: impact of hepatitis C infection. Transplantation 2011; 91: 1245-1249.
18. Winston JA, Klotman ME, Klotman PE,. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 1999; 55: 1036-1040.
19. Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, et al.; for Solid Organ Transplantation in HIV: Multi-Site Study Investigators. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl 2012; 18: 716-726.